As of June 30, 2026, RemeGen Co. Ltd. Class H carries a market capitalization of 70.83B, placing it among publicly traded companies globally. Its enterprise value stands at 65.26B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 70.83B |
| Enterprise Value | 65.26B |
RemeGen Co. Ltd. Class H's next confirmed earnings release is scheduled for March 31, 2027.
| Earnings Date | 3/31/2027 |
As of June 30, 2026, RemeGen Co. Ltd. Class H has 953.26M shares outstanding.
| Shares Outstanding | 953.26M |
These figures are as of June 30, 2026.
| PB Ratio | 7.37 |
| P/TBV Ratio | 7.40 |
As of June 30, 2026, RemeGen Co. Ltd. Class H maintains a current ratio of 4.82, meaning it holds 4.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.82 |
| Quick Ratio | 3.73 |
| Debt / Equity | 3.74 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 3,048.00 |
As of the close on November 17, 2026, RemeGen Co. Ltd. Class H's stock has declined approximately 25.75% over the past 52 weeks. The 50-day moving average sits at 70.48, while the 200-day moving average is 82.12.
| 52-Week Price Change | -25.75% |
| 50-Day Moving Average | 70.48 |
| 200-Day Moving Average | 82.12 |
As of June 30, 2026, RemeGen Co. Ltd. Class H holds 5.93B in cash and equivalents against 359.47M in total debt, resulting in a net debt position of -1.57B. Total book value stands at 9.61B, with working capital of 6.07B providing operational flexibility.
| Cash & Cash Equivalents | 5.93B |
| Total Debt | 359.47M |
| Net Debt | -1.57B |
| Equity (Book Value) | 9.61B |
| Book Value Per Share | 10.08 |
| Working Capital | 6.07B |
Already premium?